作者: Haytham El-Shurafa , Khaled D Algarni , Amr A Arafat , Sondos Samargandy , Claudio Pragliola
DOI: 10.1111/JOCS.15447
关键词:
摘要: Background The number of MtraClip procedures is increasing, and consequently, the patients with residual or recurrent mitral regurgitation (MR). We aimed to characterize who had versus MR after MitraClip report outcomes different treatment strategies. Methods From 2012 2020, 167 MitraClip. Out them, 16 (9.5%) (MR), 27 (16.2%) MR. Results median age in was 67.5 (59-73) years 69 (61-78) (p = .87). etiology valve disease functional 13 (81.3%) 22 (84.6%) > .99). Cardiac resynchronization therapy-defibrillator implantation higher .02). Survival 93.7% at 1 year, 76.4% 3 92.5% 84.5% .69). Two group re-clip, three surgery, group, one patient two surgery .23). Patients re-clip were older .09). Surgery associated 100% survival 5 years, 63% medical therapy worst reported .007). Conclusion comparable. could be improved compared re-clip.